Search

  • Sort by

  • Category

  • Post Type

  • Reset

Hosseini SA, Darbooy Sh, Tehrani Banihashemi SA, Naseri SM, Dinarvand R. Counterfeit medicines: report of a cross-sectional retrospective study in Iran. Public Health. 2011 Mar; 125(3):165-71.

March 1, 2011
Posted in , ,

OBJECTIVES: To gain insight into the pharmaceutical grey market in Iran by reviewing inspection files of the Special Inspectorate Unit, Deputy Ministry for Food and Drugs, Ministry of Health and Medical Education, and to define the counterfeit pharmaceutical pattern in Iran. STUDY DESIGN: Cross-sectional retrospective study. METHODS: In total, 382 inspection files of pharmaceutical counterfeit cases between 2007 and 2008…

Read More

PSM’s Liang in JAMA: Online Direct to Consumer Advertising’s Impact on Illegal Online Pharmacies

February 25, 2011
Posted in ,

Washington, D.C. (February 25, 2011) – Partnership for Safe Medicines Board of Directors’ member Bryan A. Liang, MD, PhD, JD, with colleague Tim Mackey, MAS, published an article in this week’s issue of the Journal of the American Medical Association (JAMA) addressing the online direct to consumer (DTC) advertising market, and specifically how rogue online pharmacies have adopted these tools…

Read More

U.K. Chemist Convicted for Drug Counterfeiting

February 25, 2011
Posted in

A University College London organic chemistry lecturer was convicted for creating and selling counterfeit medication in the United Kingdom. The Independent reports that chemist Christiaan Winkel, a Dutch national, imported a machine from China and chemicals to make £1.6 million worth of fake erectile dysfunction pills and also used the equipment to make fake Ecstacy. He pressed samples using white…

Read More

U.S. Customs Seize 20,000 Counterfeit Medications at Kennedy Airport

February 24, 2011
Posted in

At New York’s Kennedy Airport, U.S. Customs and Border Protection flagged a cargo shipment from Hong Kong labeled “Farsan Sweet Dryfruit” for inspection on Thursday, February 17, 2011, and found approximately 20,000 pills inside. Fox News New York reported that officers examined the pills and identified them as counterfeit sildenafil, tadalfil and vardenafil. “The illicit trade in pharmaceuticals poses a…

Read More

Russian Online Pharmacy Supplying Americans with Pain Pills Prescription-Free

February 24, 2011
Posted in ,

Internal documents from ChronoPay, Russia’s largest processor of online payments, have shown that a Russian rogue pharmacy program called Rx-Promotion sold millions of controlled pills including Valium, Percocet, Tramadol and Oxycodone, in 2010 alone, mostly to Americans, without prescription requirements. Reporter Brian Krebs interviewed Pavel Vrublevsky in February 2011, the founder of ChronoPay, and also received a compilation of the…

Read More

Discovery of Counterfeit Nutritional Supplements with Dangerous Ingredients Spurs Company Recall

February 23, 2011
Posted in

This is a reprint of the FDA alert. February 22, 2011 -Biotab Nutraceuticals, Inc. (“Biotab”) is conducting a voluntary recall of two lots of EXTENZE nutritional supplement tablets. Some packages bearing lot numbers 0709241 and 0509075 are counterfeit products containing undeclared drug ingredients that can pose a serious risk to health. Biotab learned about the problem after being notified by…

Read More

Liang B A*, Mackey T. Direct-to-Consumer Advertising With Interactive Internet Media. JAMA. 2011 2 23; 305 (8): 824-825.

February 23, 2011
Posted in , , , , , , , ,

Direct-to-consumer advertising (DTCA) is legal only in the United States and New Zealand and has been linked with drug overutilization, public health concerns, and higher costs. 1 Despite global proscriptions, DTCA is the most rapidly increasing form of pharmaceutical marketing, with approximately $4 billion in US expenditures, outpacing physician marketing and research and development. Liang B. A, Mackey T. Direct-to-Consumer…

Read More

Counterfeit Pills Infiltrated Over-The-Counter Nutritional Supplement Market

February 22, 2011
Posted in ,

View in a larger map On February 22, 2011, Biotab Nutraceuticals, Inc., (“Biotab”) voluntarily recalled two lots of EXTENZE nutritional supplements bearing lot number 0709241 and 0509075 because they are counterfeit products containing undeclared drug ingredients. Who: The Food and Drug Administration notified Biotab of the problem. When: February 22, 2011 Where: USA. How: Unknown counterfeiters manufactured and distributed the…

Read More

Svelte 30 Nutritional Consultants Issues a Voluntary Recall of Weight Loss Pills Found to Contain an Undeclared Drug Ingredient

February 22, 2011
Posted in

Recalled Svelte 30 Herb SupplementPhoto courtesy of the FDA via Flickr. This is a reprint of the FDA alert. February 9, 2011 – – Svelte 30 Nutritional Consultants has been informed by the Food and Drug Administration (FDA) that a sample of Svelte 30 orange & gray capsule was collected and tested by FDA in January 2011. The capsules tested positive for…

Read More

Rogue Online Pharmacies Co-Opt Google Brand

February 22, 2011
Posted in

  A new pharmaceutical spam campaign misappropriates Google branding to promote a “Google-accredited” online pharmacy portal. Symantec’s MessageLabs intelligence tracked spam email messages promoting online drug sales with a false claim that Google has hosted and approved the pharmacy sites. The link within the email directs to a spammer’s blog on a popular blogging portal, containing drug spam content and…

Read More